Type something and hit enter

ads here
On
advertise here

After the fantastic news of this weekend "CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)" all CRISPR stocks booked new ATH's with the exception of EDITAS medicine which is at a 52week high. Early innings for a Trillion dollar market...

$CRSP ATH:

https://www.reddit.com/r/CrisprTherapeutics/comments/k8pmvo/crsp_at_ath_071220/

$NTLA ATH:

https://www.reddit.com/r/IntelliaTherapeutics/comments/k8pl2p/ntla_at_ath_071220/

$BEAM ATH:

https://www.reddit.com/r/BeamTherapeutics/comments/k8pq62/beam_at_ath_071220/

$EDIT 52week high:

https://www.reddit.com/r/EditasMedicine/comments/k8pjsw/edit_at_52week_high/

Introduction to CRISPR:

Video: https://www.youtube.com/watch?v=jAhjPd4uNFY&ab_channel=Kurzgesagt%E2%80%93InaNutshell

Article I posted on wsb 6 months ago: https://www.reddit.com/r/wallstreetbets/comments/gk6up7/crispr_introduction_ntla_crsp_edit_beam/



Submitted December 07, 2020 at 04:46PM by Anonymous-Green https://ift.tt/3mW33Zr

Click to comment